Literature DB >> 808561

The regulation of calcitonin in normal human plasma as assessed by immunoprecipitation and immunoextraction.

J G Parthemore, L J Deftos, D Bronzert.   

Abstract

We have studied the secretion of calcitonin in normal adults with a new procedure of increased sensitivity for the measurement of the hormone in peripheral plasma. In this method, endogenous calcitonin is immunoprecipitated with specific antibodies from a 10-ml plasma sample. The calcitonin is then dissociated from the antibodies and extracted into alcohol. The alcohol is evaporated, and the calcitonin is recovered in assay diluent for subsequent radioimmunoassay. The procedure produces a fivefold increase in immunoassay sensitivity and eliminates plasma proteins which can produce spurious immunoassay effects. This procedure was used to measure calcitonin in normal adults. The mean (+/- SE) plasma calcitonin in 43 subjects was 10 (+/- 2) pg/ml. A+ the end of a 3-h calcium infusion (12 mg/kg), mean plasma calcitonin in 10 subjects had risen to 114 (+/- 21) pg/ml. In 11 subjects, a 10-min infusion of 150 mg of calcium caused calcitonin to rise to a mean concentration of 28 (+/- 7) pg/ml at 20 min. EDTA infusion (50 mg/kg 2 h) caused a slight decrease in plasma calcitonin. These results are consistent with our previous reports of the low concentrations of calcitonin in adult plasma. Our data may underestimate calcitonin levels since not all of the heterogenous species of hormone may be extracted by this method. In any case, this procedure has allowed us to determine that the low concentrations of plasma calcitonin in normal adults are responsive to perturbations of calcium homeostasis. The immunoextraction method may be applicable to other assays in which it is necessary to increase sensitivity or define specificity.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 808561      PMCID: PMC301938          DOI: 10.1172/JCI108162

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  A short calcium infusion in the diagnosis of medullary thyroid carcinoma.

Authors:  J G Parthemore; D Bronzert; G Roberts; L J Deftos
Journal:  J Clin Endocrinol Metab       Date:  1974-07       Impact factor: 5.958

2.  Dextran-charcoal and dioxane phase separation methods in the radioimmunoassays for parathyroid hormone and calcitonin.

Authors:  J F Habener; G P Mayer; D Powell; T M Murray; F R Singer; J T Potts
Journal:  Clin Chim Acta       Date:  1973-05-18       Impact factor: 3.786

3.  Radioimmunoassay for calcitonin in medullary thyroid carcinoma.

Authors:  L J Deftos
Journal:  JAMA       Date:  1974-01-28       Impact factor: 56.272

4.  Stimulation of thyrocalcitonin secretion by pentagastrin and calcium in 2 patients with medullary carcinoma of the thyroid.

Authors:  J F Hennessy; T K Gray; C W Cooper; D A Ontjes
Journal:  J Clin Endocrinol Metab       Date:  1973-01       Impact factor: 5.958

5.  Early diagnosis of medullary carcinoma of the thyroid gland by means of calcitonin assay.

Authors:  K E Melvin; H H Miller; A H Tashjian
Journal:  N Engl J Med       Date:  1971-11       Impact factor: 91.245

6.  Immunoassay for human calcitonin. I. Method.

Authors:  L J Deftos
Journal:  Metabolism       Date:  1971-12       Impact factor: 8.694

7.  Immunoassay of human calcitonin.

Authors:  A H Tashijan; B G Howland; K E Melvin; C S Hill
Journal:  N Engl J Med       Date:  1970-10-22       Impact factor: 91.245

8.  Immunoassay for human calcitonin. II. Clinical studies.

Authors:  L J Deftos; A E Bury; J F Habener; F R Singer; J T Potts
Journal:  Metabolism       Date:  1971-12       Impact factor: 8.694

9.  Suppression and stimulation of calcitonin secretion in medullary thyroid carcinoma.

Authors:  L J Deftos; A D Goodman; K Engelman; J T Potts
Journal:  Metabolism       Date:  1971-04       Impact factor: 8.694

10.  Secretion of calcitonin in hypocalcemic states in man.

Authors:  L J Deftos; D Powell; J G Parthemore; J T Potts
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

View more
  4 in total

1.  Plasma calcitonin in normal man. Differences between men and women.

Authors:  H Heath; G W Sizemore
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

2.  Acute responsiveness to calcitonin in chronic renal failure.

Authors:  M Cochran; C J Hillyard; G J Dew; T J Martin
Journal:  Br Med J       Date:  1976-08-14

3.  Characterization of the immunochemical forms of calcitonin released by a medullary thyroid carcinoma in tissue culture.

Authors:  D Goltzman; A S Tischler
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

4.  Pre- and postoperative studies of plasma calcitonin in primary hyperparathyroidism.

Authors:  P W Lambert; H Heath; G W Sizemore
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.